Investigating the bone marrow environment in myelofibrosis
Understanding and targeting bone marrow microenvironment in myelofibrosis
This study is looking at how the environment in the bone marrow affects primary myelofibrosis, a serious blood condition, and aims to find new treatments that could help improve outcomes for patients like you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10755697 on NIH RePORTER |
What this research studies
This research focuses on understanding how the bone marrow microenvironment contributes to primary myelofibrosis (PMF), a serious blood disorder that can lead to leukemia. The study aims to explore the interactions between leukemia stem cells and the fibrotic niche in the bone marrow, which is crucial for the disease's progression. By identifying key mediators of fibrosis and testing new therapeutic strategies, including the combination of JAK inhibitors with targeted treatments, the research seeks to improve patient outcomes. Patients may have the opportunity to participate in trials that explore these novel therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults diagnosed with primary myelofibrosis who have limited treatment options.
Not a fit: Patients with other forms of blood disorders or those who are not diagnosed with myelofibrosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for patients with myelofibrosis, potentially improving survival rates and quality of life.
How similar studies have performed: Previous research has shown promise in targeting the bone marrow microenvironment in other hematological conditions, suggesting potential for success in this novel approach.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Ding, Lei — Columbia University Health Sciences
- Study coordinator: Ding, Lei
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.